Business Wire

active-semi® Releases First New High-Performance Integrated Intelligent BLDC Motor Controller and Driver with 150MHz Arm® Cortex®-M4F MCU

Del

active-semi®, Inc. (www.active-semi.com) announced today the first member of a new family of PAC® high-performance motor controllers with the PAC5523 IC. It is supported by an Evaluation Kit (EVK) and accompanying firmware for easy and fast evaluation of advanced motor control solutions.

The new PAC5523 contains the highest-performance MCU found in an integrated motor control and driver product on the market. It contains a 150MHz Arm® Cortex®-M4F MCU with 128kB FLASH, 32kB SRAM and an integrated Floating Point Unit (FPU) with Digital Signal Processor (DSP) instructions for highly efficient implementation of motor control and drive applications. The MCU also contains 4-level code protection, a cache for high-speed FLASH access, ECC for SRAM data and a CRC engine.

The PAC5523 also integrates highly-optimized peripherals specifically designed for BLDC motor control applications.

The 70V PAC5523 is optimized for battery-powered and other BLDC applications up to 48V. Integrated with the high-performance MCU is the power management, gate drivers and signal-conditioning for 3-phase inverter applications. The PAC5523 may be directly supplied with a battery of up to 20 or higher voltages using the 70V DC/DC Buck or SEPIC controller Multi-Mode Power ManagerTM (MMPM). The PAC5523 implements a Total Hibernate ModeTM which manages battery life and system efficiency by reducing quiescent current to 18uA.

The Application-Specific Power DriversTM (ASPD) integrates 70V/1.5A gate drivers for high power applications with 2-level dead-time protection for the external MOSFET-based inverter. The Configurable Analog Front-EndTM (CAFE) contains 3 Differential Programmable Gain Amplifiers (PGAs), 4 single-ended PGAs, 10 comparators, buffers and DACs that can be used for signal sampling and filtering for the control applications, minimizing the need for external components.

“The PAC5523 contains both a high-performance and high-memory MCU with integrated 70V DC/DC Controller and Gate Drivers, configurable analog front-end, coupled with active-semi®’s Total Hibernate Mode™ and other patented features, delivers the highest-performing and smallest system design at the highest system efficiency,” says David Briggs, Vice-President and General Manager at active-semi®. “We are excited about the rapidly expanding customer base that is now ramping into production with PAC5523.”

In a small 6mm x 6mm QFN package with all of the integration, the PAC5523 can realize an extremely small BOM and physical design size for compact BLDC battery-powered applications.

The PAC5523EVK extends the PAC® family of evaluation kits (EVKs) enabling fast prototyping for various applications including power tools, garden tools, telecom fans, battery-powered vehicles, drones, radio controlled cars, and general-purpose BLDC applications. Along with active-semi®’s motor control firmware and IP library, the PAC5523 will simplify system development with sensored and sensorless FOC and sensorless trapezoidal motor control applications for high-voltage battery powered applications.

PAC5523 IC and PAC5523EVK1 are available from leading distributors.

For more information on active-semi® and Intelligent Motor Control solutions, visit https://active-semi.com/products/intelligent-motor-control.

About active-semi ®

Founded in 2004 in Silicon Valley and headquartered in Dallas, Texas, active-semi® is a rapidly emerging leader in multi-billion-dollar power management and intelligent digital motor drive IC markets. The company’s portfolio of analog and mixed signal SoCs provide scalable core platforms used in charging, powering and embedded digital control systems for industrial, commercial and consumer applications. active-semi® offers Power Application Controllers® (PAC®)DC-DC and ActivePMU™ products that significantly reduce solution size and cost, improve system reliability, and shorten system development cycle-time.

active-semi® is a multi-national company with over 170 patents granted and pending. active-semi® International Inc. is a Cayman Island corporation backed by leading Venture Capital firms, including USVP, Tenaya Capital, LG and LDV Partners.

More information at www.active-semi.com

Contact information

active-semi®
Bernd Krafthoefer, +1-214-453-1422
marketing@active-semi.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Manchester United and True Religion Launch Denim Range19.10.2018 17:37Pressemelding

Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion

Arch Insurance Announces Strategic Leadership Changes19.10.2018 13:10Pressemelding

Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These

Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 12:00Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an

Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 11:54Pressemelding

Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr

Schlumberger Announces Third-Quarter 2018 Results19.10.2018 11:00Pressemelding

Schlumberger Limited (NYSE: SLB) today reported results for the third quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Sept. 30, 2018 Jun. 30, 2018 Sept. 30, 2017 Sequential Year-on-year Revenue $8,504 $8,303 $7,905 2% 8% Pretax operating income $1,152 $1,094 $1,059 5% 9% Pretax operating margin 13.5% 13.2% 13.4% 36 bps 15 bps Net income - GAAP basis $644 $430 $545 50% 18% Net income, excluding charges & credits* $644 $594 $581 8% 11% Diluted EPS - GAAP basis $0.46 $0.31 $0.39 48% 18% Diluted EPS, excluding charges & credits* $0.46 $0.43 $0.42 7% 10% North America revenue $3,189 $3,139 $2,602 2% 23% International revenue $5,215 $5,065 $5,147 3% 1% North America revenue, excluding Cameron $2,572 $2,546 $2,086 1% 23% International revenue, excluding Cameron $4,559 $4,387 $4,430 4% 3% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commented, “Our third

Tradeshift Announces Q3 2018 Results19.10.2018 11:00Pressemelding

Tradeshift, the leader in supply chain payments and marketplaces, today announced results from the third quarter of 2018, marking the tenth quarter in a row of successive growth and beating targets. Tradeshift’s third quarter growth stats announced today include: YoY revenue grew 400 percent (trailing 12 months) YoY new bookings grew 284 percent YoY gross merchandise volume (GMV) grew 262 percent New total contract value grew by $47M in Q3 Tradeshift’s customer roster continued strong growth this quarter adding 27 new customers, including Hertz, Shiseido, ECU, and Fortune 500 leaders in retail apparel, agriculture, engineering and construction, hospitality, travel and food delivery. Tradeshift also expanded its app ecosystem by adding a key partnership with Coface, a global credit insurer. Coface has announced a new app solution on the Tradeshift platform offering risk and business information services to help businesses make decisions by ensuring greater financial transparency between